Introduction

Hypertension is a significant burden on the Australian healthcare system. In 2017 to 2018, close to 6.3 million adult Australians reported having measured high blood pressure (BP), hypertension as a medical condition or the use of antihypertensive medicines.1

Learning objectives

After successful completion of this CPD activity, pharmacists should be able to:

  • Discuss current guidelines for the management of hypertension
  • Explain the importance of absolute cardiovascular risk assessment in guiding hypertension treatment decisions
  • Describe the role of the pharmacist in supporting patients with hypertension, including monitoring and referral when indicated

Competencies standards addressed (2016): 1.1, 1.3, 1.6, 2.3, 2.4, 3.1, 3.5, 3.6

Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.  

Management of hypertension is a key component of risk factor modification in both primary and secondary prevention of cardiovascular disease (CVD) and end organ damage.2,3 The high prevalence of hypertension means that it is often managed in the setting of additional co-morbid conditions, requiring judicious use of the wide range of available hypertension treatment options.

This article will discuss the management of hypertension in the context of absolute cardiovascular risk and primary prevention. Recommendations for non-pharmacological and pharmacological antihypertensive management from key Australian cardiology guidelines will be explored, with consideration of treatment strategies and options in the setting of co-morbid conditions. Finally, this article will explore the role of the pharmacist in the treatment of hypertension with regards to medication safety, monitoring and patient education.

Hypertension and Abs

THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.